GO:0043353 | enucleate erythrocyte differentiation | 1 | 6 |
GO:0042802 | identical protein binding | 2 | 354 |
GO:0048667 | cell morphogenesis involved in neuron differentiation | 1 | 5 |
GO:0005515 | protein binding | 50 | 4124 |
GO:0045892 | negative regulation of transcription, DNA-templated | 1 | 317 |
GO:0034349 | glial cell apoptotic process | 1 | 4 |
GO:0051402 | neuron apoptotic process | 1 | 30 |
GO:0000278 | mitotic cell cycle | 9 | 314 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 1 | 15 |
GO:0031175 | neuron projection development | 2 | 55 |
GO:0031625 | ubiquitin protein ligase binding | 2 | 138 |
GO:0035914 | skeletal muscle cell differentiation | 1 | 33 |
GO:0071459 | protein localization to chromosome, centromeric region | 1 | 3 |
GO:0051146 | striated muscle cell differentiation | 2 | 12 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 1 | 45 |
GO:0035189 | Rb-E2F complex | 1 | 4 |
GO:0071922 | regulation of cohesin localization to chromatin | 2 | 4 |
GO:0003713 | transcription coactivator activity | 3 | 184 |
GO:0007070 | negative regulation of transcription from RNA polymerase II promoter during mitosis | 1 | 2 |
GO:0007093 | mitotic cell cycle checkpoint | 2 | 25 |
GO:0005819 | spindle | 2 | 80 |
GO:0006351 | transcription, DNA-templated | 15 | 1076 |
GO:0031134 | sister chromatid biorientation | 1 | 1 |
GO:0045445 | myoblast differentiation | 1 | 13 |
GO:0019900 | kinase binding | 2 | 32 |
GO:0016605 | PML body | 1 | 79 |
GO:0000075 | cell cycle checkpoint | 1 | 6 |
GO:0007050 | cell cycle arrest | 2 | 92 |
GO:0006338 | chromatin remodeling | 2 | 55 |
GO:0005654 | nucleoplasm | 16 | 876 |
GO:0045893 | positive regulation of transcription, DNA-templated | 6 | 377 |
GO:0043550 | regulation of lipid kinase activity | 1 | 4 |
GO:0042551 | neuron maturation | 1 | 10 |
GO:0007346 | regulation of mitotic cell cycle | 1 | 21 |
GO:0016514 | SWI/SNF complex | 1 | 13 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 9 | 582 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 1 | 5 |
GO:0030521 | androgen receptor signaling pathway | 3 | 35 |
GO:0097284 | hepatocyte apoptotic process | 1 | 9 |
GO:0050680 | negative regulation of epithelial cell proliferation | 1 | 39 |
GO:0045879 | negative regulation of smoothened signaling pathway | 1 | 15 |
GO:0016032 | viral process | 13 | 428 |
GO:0000785 | chromatin | 2 | 59 |
GO:0006469 | negative regulation of protein kinase activity | 1 | 50 |
GO:0034088 | maintenance of mitotic sister chromatid cohesion | 1 | 2 |
GO:0090230 | regulation of centromere complex assembly | 1 | 1 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 8 | 644 |
GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle | 1 | 3 |
GO:0050681 | androgen receptor binding | 2 | 30 |
GO:0005634 | nucleus | 40 | 3246 |
GO:0045651 | positive regulation of macrophage differentiation | 1 | 10 |
GO:0001102 | RNA polymerase II activating transcription factor binding | 1 | 31 |
GO:0003677 | DNA binding | 12 | 947 |
GO:0007265 | Ras protein signal transduction | 2 | 59 |
GO:0001047 | core promoter binding | 1 | 42 |
GO:0000082 | G1/S transition of mitotic cell cycle | 6 | 125 |
GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle | 1 | 21 |
GO:0051219 | phosphoprotein binding | 3 | 25 |
GO:0048565 | digestive tract development | 1 | 19 |
GO:0008134 | transcription factor binding | 5 | 209 |